Cargando…

CYFRA 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value

OBJECTIVES: Chosen cutoff for cytokeratin 19 fragment antigen (CYFRA 21-1) as a tumor biomarker considerably influences its diagnostic and prognostic usefulness. The aim of the present study is to determine an optimal cutoff value for diagnostic validity of CYFRA 21-1 by Lumipulse (®) technology in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Garcia-Valdecasas Gayo, Sonsoles, Ruiz-Alvarez, Maria Jesus, Gonzalez-Gay, Daniel, Ramos-Corral, Raquel, Marquez-Lietor, Eva, Del Amo, Nazaret, Plata, Maria del Carmen, Guillén-Santos, Raquel, Arribas, Ignacio, Cava-Valenciano, Fernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197668/ https://www.ncbi.nlm.nih.gov/pubmed/37360615 http://dx.doi.org/10.1515/almed-2020-0005

Ejemplares similares

El CYFRA 21-1 en pacientes con sospecha de cáncer: evaluación de un punto de corte óptimo para evaluar la eficacia diagnóstica y el valor pronóstico
por: Garcia-Valdecasas Gayo, Sonsoles, et al.
Publicado: (2020)

The Need for a CYFRA 21-1 Cutoff Value to Predict Clinical Progression of IPF in Clinical Practice
por: Fujimoto, Hajime, et al.
Publicado: (2022)

Reply to Fujimoto et al.: The Need for a CYFRA 21-1 Cutoff Value to Predict Clinical Progression of IPF in Clinical Practice
por: Molyneaux, Philip L., et al.
Publicado: (2022)

Evaluation of serum cyfra21 in patients with pleural effusion
por: Azimi, Q, et al.
Publicado: (2012)

Clinical significance of serum CYFRA 21-1 in gastric cancer.
por: Nakata, B., et al.
Publicado: (1996)

CYFRA 21-1 in urine: a diagnostic marker for endometriosis?
por: Gjavotchanoff, Risto
Publicado: (2015)

On Target: CYFRA 21-1 as an Idiopathic Pulmonary Fibrosis Biomarker
por: Spagnolo, Paolo, et al.
Publicado: (2022)

Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis
por: Zhang, Zhen, et al.
Publicado: (2017)

CYFRA 21-1 and Placental Growth Factor as Screening Markers for Endometriosis
por: Cho, Hye-yon, et al.
Publicado: (2019)

Prognostic Role of Serum Cytokeratin-19 Fragment (CYFRA 21-1) in Patients with Hepatocellular Carcinoma
por: Caviglia, Gian Paolo, et al.
Publicado: (2020)

CYFRA 21-1 serum levels in women with adnexal masses and inflammatory diseases.
por: Tempfer, C., et al.
Publicado: (1998)

Increases in Serum CYFRA21-1 Concentration during Successful Treatment with Crizotinib
por: Kanaji, Nobuhiro, et al.
Publicado: (2014)

Serum Levels of Cyfra 21 in Patients with Benign and Malignant Salivary Gland Tumors
por: Jeiroodi, Naghmeh, et al.
Publicado: (2017)

Evaluation of CYFRA 21.1 as a Dedifferentiation Marker of Advanced Thyroid Cancer
por: Malapure, Sumeet Suresh, et al.
Publicado: (2020)

Role of Serum CYFRA 21-1 in Diagnosis and Prognostic in Colorectal Liver Metastases
por: Li, Shirong, et al.
Publicado: (2023)

Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions.
por: Salama, G., et al.
Publicado: (1998)

Diagnostic and prognostic values of cerebrospinal fluid CYFRA 21-1 in patients with leptomeningeal carcinomatosis
por: Hyun, Jae-Won, et al.
Publicado: (2017)

Elevated serum CYFRA 21‐1 level as a diagnostic marker for thymic carcinoma
por: Shiiya, Haruhiko, et al.
Publicado: (2021)

Assay Performance of a Label-Free, Solution-Phase CYFRA 21-1 Determination
por: Kussrow, Amanda K., et al.
Publicado: (2022)

Cytokeratin-19 fragments in serum (CYFRA 21-1) as a marker in primary liver cancer
por: Uenishi, T, et al.
Publicado: (2003)

Prognostic value of serum CYFRA21-1 and CEA for non-small-cell lung cancer
por: Zhang, Zhi-Hui, et al.
Publicado: (2015)

Serum markers of CYFRA 21-1 and C-reactive proteins in oral squamous cell carcinoma
por: Hsu, Yin-Ping, et al.
Publicado: (2015)

The usefulness of CYFRA 21–1 to diagnose and predict preeclampsia: a nested case-control study
por: Kuessel, Lorenz, et al.
Publicado: (2016)

Postoperative CYFRA 21-1 and CEA as prognostic factors in patients with stage I pulmonary adenocarcinoma
por: He, Ying, et al.
Publicado: (2017)

Diagnostic value analysis of combined detection of Trx, CYFRA21-1 and SCCA in lung cancer
por: Qu, Tao, et al.
Publicado: (2019)

Serum CYFRA 21-1 but not Vimentin is Associated with Poor Prognosis in Advanced Lung Cancer Patients
por: Kanaji, Nobuhiro, et al.
Publicado: (2019)

Serum CYFRA 21.1 Level Predicts Disease Course in Thyroid Cancer with Distant Metastasis
por: Jeong, Chaiho, et al.
Publicado: (2021)

Word Embedding Reveals Cyfra 21-1 as a Biomarker for Chronic Obstructive Pulmonary Disease
por: Heo, Jeongwon, et al.
Publicado: (2021)

Diagnostic Value of FTO Combined with CEA or CYFRA21-1 in Nonsmall Cell Lung Cancer
por: Shang, Liqun, et al.
Publicado: (2021)

CYFRA21-1 is a more sensitive biomarker to assess the severity of pulmonary alveolar proteinosis
por: Bai, Jiu-Wu, et al.
Publicado: (2022)

Simple diagnosis of cancer by detecting CEA and CYFRA 21-1 in saliva using electronic sensors
por: Joshi, Sowmya, et al.
Publicado: (2022)

Estimation of salivary and serum CYFRA 21-1 levels in patients with oral squamous cell carcinoma
por: Adusumilli, Praveena, et al.
Publicado: (2023)

Measurement of cytokeratin 19 fragments as a marker of lung cancer by CYFRA 21-1 enzyme immunoassay.
por: Takada, M., et al.
Publicado: (1995)

Assessment of Confounding Factors Affecting the Tumor Markers SMRP, CA125, and CYFRA21-1 in Serum
por: Weber, Daniel Gilbert, et al.
Publicado: (2010)

Prognostic impact of serum CYFRA 21–1 in patients with advanced lung adenocarcinoma: a retrospective study
por: Ono, Akira, et al.
Publicado: (2013)

A Comparison of Serum CYFRA 21-1 and SCC Ag in the Diagnosis of Squamous Cell Lung Carcinoma
por: Kim, Young-Chul, et al.
Publicado: (1996)

Impact of HSP90α, CEA, NSE, SCC, and CYFRA21-1 on Lung Cancer Patients
por: Zhou, Wenwen, et al.
Publicado: (2021)

AB010. Clinical significance of serum Cyfra 21-1 as a marker in thymic epithelial tumors
por: Hao, Xiuxiu, et al.
Publicado: (2022)

Prognostic value of CYFRA 21 − 1 and Ki67 in advanced NSCLC patients with wild-type EGFR
por: Li, Tao, et al.
Publicado: (2023)

Retracted: Diagnostic Value of FTO Combined with CEA or CYFRA21-1 in Nonsmall Cell Lung Cancer
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3ukm8lboicsv7nh2m00hurrgfj